MX2017012878A - Composiciones gomosas de multicomponentes con nucleo duro. - Google Patents

Composiciones gomosas de multicomponentes con nucleo duro.

Info

Publication number
MX2017012878A
MX2017012878A MX2017012878A MX2017012878A MX2017012878A MX 2017012878 A MX2017012878 A MX 2017012878A MX 2017012878 A MX2017012878 A MX 2017012878A MX 2017012878 A MX2017012878 A MX 2017012878A MX 2017012878 A MX2017012878 A MX 2017012878A
Authority
MX
Mexico
Prior art keywords
multicomponent
component
hard core
dosage forms
shell capsule
Prior art date
Application number
MX2017012878A
Other languages
English (en)
Inventor
Romanoschi Ovidiu
MUNIZ Luis
Oryniak Caryn
Bagley Lindsey
Huatan Hiep
Kanji Nazim
Jones Huw
Godfrey Graham
Original Assignee
Church & Dwight Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Church & Dwight Co Inc filed Critical Church & Dwight Co Inc
Publication of MX2017012878A publication Critical patent/MX2017012878A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/50—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by shape, structure or physical form, e.g. products with supported structure
    • A23G3/54—Composite products, e.g. layered, coated, filled
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente descripción de la invención se refiere a formas de dosificación orales masticables que son adecuadas para la administración de uno o más ingredientes activos a un consumidor, particularmente, a un individuo humano. Las formas de dosificación pueden configurarse como composiciones de multicomponentes formadas por: un primer componente que incluye una composición gomosa; un segundo componente que es un material particulado o es una unidad sólida preformada o una pluralidad de unidades sólidas preformadas; y un ingrediente activo. El segundo componente puede estar, por ejemplo, en la forma de una unidad de dosificación oral farmacéuticamente aceptable, tal como una tableta, una capleta, una cápsula de cubierta blanda, una cápsula de cubierta dura, una microcápsula o una pastilla.
MX2017012878A 2015-04-07 2016-04-06 Composiciones gomosas de multicomponentes con nucleo duro. MX2017012878A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562144224P 2015-04-07 2015-04-07
US201562238947P 2015-10-08 2015-10-08
PCT/US2016/026219 WO2016164464A1 (en) 2015-04-07 2016-04-06 Multicomponent gummy compositions with hard core

Publications (1)

Publication Number Publication Date
MX2017012878A true MX2017012878A (es) 2018-08-15

Family

ID=57072920

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017012878A MX2017012878A (es) 2015-04-07 2016-04-06 Composiciones gomosas de multicomponentes con nucleo duro.
MX2017012877A MX2017012877A (es) 2015-04-07 2016-04-06 Composiciones gomosas de multicomponentes con nucleo suave.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2017012877A MX2017012877A (es) 2015-04-07 2016-04-06 Composiciones gomosas de multicomponentes con nucleo suave.

Country Status (8)

Country Link
US (3) US11154495B2 (es)
EP (2) EP3280273B1 (es)
CN (2) CN107613918B (es)
AU (2) AU2016246580B2 (es)
CA (2) CA2981759C (es)
ES (1) ES2968450T3 (es)
MX (2) MX2017012878A (es)
WO (2) WO2016164464A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018160295A1 (en) * 2017-01-25 2018-09-07 Yiannios James John Dietary supplement compositions with enhanced delivery matrix, gummies, chocolates, atomizers and powders containing same, and methods of making same
US10206572B1 (en) 2017-10-10 2019-02-19 Carrot, Inc. Systems and methods for quantification of, and prediction of smoking behavior
CA2981759C (en) * 2015-04-07 2021-10-12 Church & Dwight Co., Inc. Multicomponent gummy compositions with soft core
US20170340000A1 (en) * 2016-05-31 2017-11-30 William Willard Drink container delivery system
US10960076B2 (en) 2017-01-25 2021-03-30 Church & Dwight Co. Inc. Gummy dosage forms comprising serine
CN110519996A (zh) * 2017-03-01 2019-11-29 丘奇和德怀特有限公司 具有改进的稳定性的胶粘组合物
AU2018239993B2 (en) * 2017-03-20 2024-01-25 Bayer Healthcare Llc Chewable gel products for active pharmaceutical ingredients
CN112312915A (zh) * 2018-06-11 2021-02-02 西雅图咖米公司 低血糖胶粘组合物及其制备和使用方法
US11273123B2 (en) 2018-07-18 2022-03-15 USpharma Ltd Chewable pharmaceutical dosage forms
IL262768B (en) 2018-11-04 2020-08-31 Ambrosia Supherb Ltd Chewable tablet and method for its preparation
CN110046697A (zh) * 2019-04-26 2019-07-23 北京理工大学 一种基于K指数的Kp指数现报方法
IT201900006491A1 (it) * 2019-05-02 2020-11-02 Pnk Farm Srl Forme farmaceutiche o nutraceutiche funzionalizzate
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US20210169868A1 (en) * 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral compositions with reduced water content
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
US20220062350A1 (en) * 2020-09-03 2022-03-03 Pharmavite Llc Oil-in-water emulsion gummy composition
US20240000730A1 (en) * 2020-12-01 2024-01-04 Seattle Gummy Company Antihistamine semi-solid chewable gel compositions and methods of making and using thereof
MX2023010739A (es) * 2021-03-12 2023-09-20 Nicoventures Trading Ltd Productos orales con sistema autoemulsificante.
US20230000764A1 (en) * 2021-06-11 2023-01-05 Boa Nutrition, Inc. Pressurized nutritional supplement delivery
US20240277003A1 (en) * 2021-06-18 2024-08-22 Seattle Gummy Company Chewable gel compositions with extended oral resident time and methods of making and using thereof
US12053484B2 (en) 2021-10-29 2024-08-06 Medicated Chews, Llc Simethicone chewable composition
WO2023158816A1 (en) * 2022-02-18 2023-08-24 Transport Authority, Inc. Layered edible product for multi-stage dosing of multi-function active pharmaceutical ingredients
US12016359B2 (en) 2022-11-11 2024-06-25 Pharmavite Llc Oil-in-water emulsion gummy composition with water soluble active ingredient(s)
BE1031104B1 (nl) * 2022-12-05 2024-07-01 Cosmotrend Bv Werkwijze en systeem voor het maken van gummy consumptieartikelen omvattende functionele ingrediënten
US20240188583A1 (en) * 2022-12-07 2024-06-13 Santiago Martinez Torres Filled gummies and formulations thereof

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004595A (en) 1986-12-23 1991-04-02 Warner-Lambert Company Multiple encapsulated flavor delivery system and method of preparation
US6056992A (en) 1988-06-02 2000-05-02 Campbell Soup Company Encapsulated additives
US5759599A (en) 1992-03-30 1998-06-02 Givaudan Roure Flavors Corporation Method of flavoring and mechanically processing foods with polymer encapsulated flavor oils
US5690990A (en) 1994-03-04 1997-11-25 Arnhem, Inc. Process for encapsulating the flavor with colloid gel matrix
US6117455A (en) 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
JP3881699B2 (ja) 1996-10-09 2007-02-14 ジボーダン―ルール（アンテルナシヨナル）ソシエテ アノニム 食品添加剤としてのビーズの製造方法
AU5105398A (en) * 1996-11-15 1998-06-03 Fmc Corporation Hydrocolloid delivery system
US6039901A (en) 1997-01-31 2000-03-21 Givaudan Roure Flavors Corporation Enzymatically protein encapsulating oil particles by complex coacervation
US6045835A (en) 1997-10-08 2000-04-04 Givaudan Roure (International) Sa Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
US6106875A (en) 1997-10-08 2000-08-22 Givaudan Roure (International) Sa Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
US6292814B1 (en) 1998-06-26 2001-09-18 Hitachi America, Ltd. Methods and apparatus for implementing a sign function
US6060078A (en) 1998-09-28 2000-05-09 Sae Han Pharm Co., Ltd. Chewable tablet and process for preparation thereof
BR9915276A (pt) * 1998-11-13 2001-08-07 Warner Lambert Co Compostos de confeitaria macios não arderentes e métodos de fazer os mesmos
MXPA01010377A (es) 1999-04-13 2002-10-23 Beecham Pharm Pte Ltd Metodo novedoso de tratamiento.
EP1176874A1 (en) * 1999-05-12 2002-02-06 CP Kelco ApS Food composition with high solids content, a method for its preparation as well as the use of carrageenans for gelling a food composition
ZA200003120B (en) 1999-06-30 2001-01-02 Givaudan Roure Int Encapsulation of active ingredients.
EP1136067A1 (en) 2000-03-23 2001-09-26 Pfizer Limited Oral formulations of medicaments
GB2367736A (en) * 2000-10-10 2002-04-17 Nestle Sa Water-based hydrocolloid casing
US6602518B2 (en) * 2001-06-28 2003-08-05 Wm. Wrigley Jr. Company Chewable product including active ingredient
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
ES2302926T5 (es) * 2002-04-25 2012-08-23 Banner Pharmacaps, Inc. Cápsula blanda masticable
AU2004261113B2 (en) 2003-07-31 2007-12-13 Morinaga Milk Industry Co., Ltd. Masticatable capsule and process for producing the same
US20050260329A1 (en) * 2004-05-18 2005-11-24 Christianita Yusuf Production of liquid center filled confections
US20060263475A1 (en) * 2004-08-25 2006-11-23 Cadbury Adams Usa, Llc. Center-filled chewing gum composition
US9271817B2 (en) 2005-07-05 2016-03-01 Cook Biotech Incorporated Tissue augmentation devices and methods
US20070141198A1 (en) * 2005-12-21 2007-06-21 Marguerite Yang Multilayered confectionery products and methods regarding same
US20080063748A1 (en) 2006-09-08 2008-03-13 Cadbury Adams Usa Llc. Center-fill confectionery and chewing gum compositions containing suspended saccharide particles
CA2665226C (en) 2006-10-05 2014-05-13 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
CA2673309A1 (en) * 2006-12-21 2008-07-03 Wm. Wrigley Jr. Company Center-filled confectionery products
AU2007353824A1 (en) 2007-04-06 2008-11-27 Source Precision Medicine, Inc. Gene expression profiling for identification, monitoring, and treatment of cervical cancer
EP2164346A1 (en) * 2007-04-09 2010-03-24 Cadbury Adams USA LLC Edible products for treatment of nasal passages
US20100184785A1 (en) * 2007-06-06 2010-07-22 Basf Se Pharmaceutical formulation for the production of chewable tablets and lozenges
US8404275B2 (en) * 2007-07-01 2013-03-26 Vitalis Llc Combination tablet with chewable outer layer
WO2009007769A1 (en) 2007-07-06 2009-01-15 Gumlink A/S Multi-modular chewing gum tablet
US20100003390A1 (en) 2008-07-03 2010-01-07 Avid Health, Inc. Method for adding functional components to hydrocolloid bases that require cooking
BRPI0917026A2 (pt) * 2008-08-08 2016-02-16 Mcneil Ppc Inc uso de sucralose como agente granulador
US20100226904A1 (en) 2009-03-05 2010-09-09 Hero Nutritionals, LLC Organic chewable supplement
US20100330058A1 (en) 2009-06-24 2010-12-30 Hero Nutritionals, LLC Chewable drug
CA2706272C (en) * 2010-06-03 2020-05-05 Accucaps Industries Limited Multi phase soft gel capsules, apparatus and method thereof
US20120035277A1 (en) * 2010-08-04 2012-02-09 Hero Nutritionals, LLC Liquid-filled chewable supplement
WO2012106582A2 (en) * 2011-02-03 2012-08-09 Snap Infusion Llc Confection composition
EP2500016A1 (en) 2011-03-18 2012-09-19 Laboratorios Del. Dr. Esteve, S.A. Doxylamine resinate complex
CN102813275B (zh) * 2011-06-10 2015-09-30 杭州养生堂保健品有限公司 一种咀嚼型软胶囊皮和咀嚼型软胶囊
US9763928B2 (en) * 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
WO2013136183A2 (en) 2012-03-12 2013-09-19 Innolipid, As Oxidixable fatty acid composition delivery form
US20130316053A1 (en) 2012-05-25 2013-11-28 Martin Rifkin Methods of making center-in-shell chewable compositions with functional components
US20130287899A1 (en) 2012-04-25 2013-10-31 Avid Health, Inc. Center-in-shell chewable compositions with functional components
US20160045433A1 (en) 2014-08-13 2016-02-18 Debbie Whitney Children's Medication Delivery Device
CA2981759C (en) * 2015-04-07 2021-10-12 Church & Dwight Co., Inc. Multicomponent gummy compositions with soft core

Also Published As

Publication number Publication date
US10786447B2 (en) 2020-09-29
CA2981759C (en) 2021-10-12
AU2016246580B2 (en) 2020-12-17
WO2016164470A1 (en) 2016-10-13
CA2981759A1 (en) 2016-10-13
EP3280370A1 (en) 2018-02-14
EP3280370A4 (en) 2019-01-02
EP3280273A1 (en) 2018-02-14
CA2981752A1 (en) 2016-10-13
ES2968450T3 (es) 2024-05-09
US20160296474A1 (en) 2016-10-13
EP3280273A4 (en) 2018-11-14
CN107613789A (zh) 2018-01-19
MX2017012877A (es) 2018-07-06
CN107613918B (zh) 2021-03-09
AU2016246580A1 (en) 2017-10-26
CN107613918A (zh) 2018-01-19
US20200000716A1 (en) 2020-01-02
EP3280273B1 (en) 2023-10-18
US11154495B2 (en) 2021-10-26
US10328023B2 (en) 2019-06-25
WO2016164464A1 (en) 2016-10-13
CA2981752C (en) 2020-08-25
US20160296470A1 (en) 2016-10-13
AU2016246583B2 (en) 2020-06-25
AU2016246583A1 (en) 2017-10-26

Similar Documents

Publication Publication Date Title
MX2017012878A (es) Composiciones gomosas de multicomponentes con nucleo duro.
GB2541835A (en) Multivesicular liposome formulations of tranexamic acid
PH12020550341A1 (en) Niraparib formulations
JP2015523407A5 (es)
MX2018000546A (es) Composiciones farmaceuticas que contienen celecoxib y tramadol.
WO2011104652A3 (en) Veterinary compositions
MX2021016109A (es) Metodos y composiciones particularmente para el tratamiento del trastorno por deficit de atencion.
MX2014008284A (es) Formulacion de liberacion retardada para reducir la frecuencia de orinar y metodos de uso de esta.
WO2017037075A8 (de) Zusammensetzung enthaltend einen extrakt aus echinacea und linolsäurederivate
MX2017013636A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas.
PH12015501377A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
MX2017005163A (es) Composiciones de liberación prolongada de onapristona y métodos.
MX2021004300A (es) Capsulas blandas con matriz de relleno polimerico solido o similar a un gel.
GR1008228B (el) Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου
PH12019500024A1 (en) Pharmaceutical compositions
WO2015022560A8 (en) Stable pharmaceutical composition containing bisoprolol and ramipril
WO2015166419A3 (es) Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor
MX2018010065A (es) Forma de dosificacion oral que comprende rifaximina en forma beta.
MX2017013643A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y una matriz.
MX2019015869A (es) Nuevas formulaciones orales de belinostat.
PE20141688A1 (es) Combinacion farmaceutica antineuritica y composiciones
MX2017013634A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y un polvo.
MX2018015759A (es) Regimenes de dosificacion de vortioxetina para el rapido inicio del efecto antidepresivo.
MX2017014725A (es) Dropropizina en combinacion con ambroxol en la forma farmaceutica de jarabe y tabletas.
PH12020550597A1 (en) Formulation having improved hygroscopic property and dissolution rate comprising telmisartan or its pharmaceutically acceptable salt